What are the chances they run all three Diseases in the same trial?.
Makes a lot of sense to me.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.74%
!
$16.99

Ann: Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.99 |
Change
-0.300(1.74%) |
Mkt cap ! $2.159B |
Open | High | Low | Value | Volume |
$17.08 | $17.67 | $16.97 | $5.264M | 304.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 108 | $16.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.99 | 143 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 204 | 16.990 |
7 | 520 | 16.980 |
9 | 1604 | 16.970 |
7 | 509 | 16.960 |
7 | 2324 | 16.950 |
Price($) | Vol. | No. |
---|---|---|
17.000 | 169 | 2 |
17.010 | 569 | 6 |
17.020 | 713 | 8 |
17.030 | 597 | 9 |
17.040 | 1199 | 7 |
Last trade - 15.22pm 01/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online